Fresenius SE Cost of Goods Sold 2016-2024 | FSNUY

Fresenius SE annual/quarterly cost of goods sold history and growth rate from 2016 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Fresenius SE cost of goods sold for the quarter ending June 30, 2024 was $4.563B, a 47.86% decline year-over-year.
  • Fresenius SE cost of goods sold for the twelve months ending June 30, 2024 was $10.857B, a 67.01% decline year-over-year.
  • Fresenius SE annual cost of goods sold for 2023 was $18.66B, a 41.19% decline from 2022.
  • Fresenius SE annual cost of goods sold for 2022 was $31.729B, a 1.43% decline from 2021.
  • Fresenius SE annual cost of goods sold for 2021 was $32.191B, a 8.55% increase from 2020.
Fresenius SE Annual Cost of Goods Sold
(Millions of US $)
2023 $18,660
2022 $31,729
2021 $32,191
2020 $29,655
2019 $28,068
2018 $27,985
2017 $26,460
2016 $22,082
2015 $21,200
Fresenius SE Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $4,563
2024-03-31 $4,666
2023-12-31 $-2,993
2023-09-30 $4,621
2023-06-30 $8,752
2023-03-31 $8,280
2022-12-31 $8,071
2022-09-30 $7,810
2022-06-30 $7,811
2022-03-31 $8,037
2021-12-31 $8,317
2021-09-30 $8,020
2021-06-30 $7,986
2021-03-31 $7,868
2020-12-31 $8,027
2020-09-30 $7,498
2020-06-30 $7,013
2020-03-31 $7,118
2019-12-31 $7,314
2019-09-30 $6,978
2019-06-30 $6,972
2019-03-31 $6,805
2018-12-31 $7,099
2018-09-30 $6,741
2018-06-30 $7,036
2018-03-31 $7,108
2017-12-31 $7,116
2017-09-30 $6,824
2017-06-30 $6,480
2017-03-31 $6,041
2016-12-31 $5,726
2016-09-30 $5,567
2016-06-30 $5,524
2016-03-31 $5,266
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.704B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00